Active-ingredient Dossier
Misoprostol
Active-ingredient Dossier for Misoprostol (prostaglandin analogue). Australian brands, products, PBS listings, PBAC outcomes — compiled by arcimedes.
- Brand: MS-2 Step
- Brand: GyMiso
- Brand: ANGUSTA
- Brand: CYTOTEC
- Brand: ARZESTRA
- Brand: CYTOTEC
- Therapeutic area: Reproductive Health
- Therapeutic area: Gastroenterology
What is
Misoprostol Misoprostol is a prostaglandin analogue.
Australian brands containing
Misoprostol — MS-2 Step — GyMiso — ANGUSTA — CYTOTEC
Therapeutic areas
Misoprostol is registered in Women's Health (2 brands), Reproductive Health (2 brands), and Gastroenterology (2 brands).
Sponsor landscape
Misoprostol is marketed by five sponsors: MS Health, Norgine, Anthia Life Sciences, Pfizer, and Proqualix Pty Ltd.
PBS and regulatory activity
The latest AusPAR for a misoprostol brand was published on 28 June 2023, with two brands holding AusPARs on record. No brands have PBAC outcomes on record.